000200247312/312024Q3false3.5xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureutr:Dbow:underwritingDivision00020024732024-01-012024-09-3000020024732024-10-0500020024732024-09-3000020024732023-12-3100020024732024-07-012024-09-3000020024732023-07-012023-09-3000020024732023-01-012023-09-300002002473us-gaap:CommonStockMember2023-12-310002002473us-gaap:AdditionalPaidInCapitalMember2023-12-310002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310002002473us-gaap:RetainedEarningsMember2023-12-310002002473us-gaap:RetainedEarningsMember2024-01-012024-03-3100020024732024-01-012024-03-310002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310002002473us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-3100020024732024-04-012024-06-300002002473us-gaap:CommonStockMember2024-03-3100020024732024-03-310002002473us-gaap:AdditionalPaidInCapitalMember2024-03-310002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310002002473us-gaap:RetainedEarningsMember2024-03-310002002473us-gaap:RetainedEarningsMember2024-04-012024-06-300002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300002002473us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300002002473us-gaap:CommonStockMember2024-04-012024-06-300002002473us-gaap:CommonStockMember2024-06-3000020024732024-06-300002002473us-gaap:AdditionalPaidInCapitalMember2024-06-300002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300002002473us-gaap:RetainedEarningsMember2024-06-300002002473us-gaap:RetainedEarningsMember2024-07-012024-09-300002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300002002473us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300002002473us-gaap:CommonStockMember2024-09-300002002473us-gaap:AdditionalPaidInCapitalMember2024-09-300002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300002002473us-gaap:RetainedEarningsMember2024-09-300002002473us-gaap:CommonStockMember2022-12-3100020024732022-12-310002002473us-gaap:AdditionalPaidInCapitalMember2022-12-310002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310002002473us-gaap:RetainedEarningsMember2022-12-310002002473us-gaap:RetainedEarningsMember2023-01-012023-03-3100020024732023-01-012023-03-310002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310002002473us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310002002473us-gaap:CommonStockMember2023-03-3100020024732023-03-310002002473us-gaap:AdditionalPaidInCapitalMember2023-03-310002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310002002473us-gaap:RetainedEarningsMember2023-03-310002002473us-gaap:RetainedEarningsMember2023-04-012023-06-3000020024732023-04-012023-06-300002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300002002473us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300002002473us-gaap:CommonStockMember2023-06-3000020024732023-06-300002002473us-gaap:AdditionalPaidInCapitalMember2023-06-300002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300002002473us-gaap:RetainedEarningsMember2023-06-300002002473us-gaap:RetainedEarningsMember2023-07-012023-09-300002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300002002473us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300002002473us-gaap:CommonStockMember2023-09-3000020024732023-09-300002002473us-gaap:AdditionalPaidInCapitalMember2023-09-300002002473us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300002002473us-gaap:RetainedEarningsMember2023-09-300002002473bow:AmFamMemberus-gaap:RelatedPartyMember2024-09-300002002473bow:AmFamMemberus-gaap:RelatedPartyMember2024-09-3000020024732024-05-092024-05-0900020024732024-05-0900020024732024-05-080002002473us-gaap:IPOMember2024-05-282024-05-280002002473us-gaap:IPOMember2024-05-280002002473us-gaap:OverAllotmentOptionMember2024-05-282024-05-280002002473us-gaap:USTreasuryAndGovernmentMember2024-09-300002002473us-gaap:USStatesAndPoliticalSubdivisionsMember2024-09-300002002473us-gaap:CommercialMortgageBackedSecuritiesMember2024-09-300002002473us-gaap:ResidentialMortgageBackedSecuritiesMember2024-09-300002002473us-gaap:AssetBackedSecuritiesMember2024-09-300002002473us-gaap:CorporateDebtSecuritiesMember2024-09-300002002473us-gaap:USTreasuryAndGovernmentMember2023-12-310002002473us-gaap:USStatesAndPoliticalSubdivisionsMember2023-12-310002002473us-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310002002473us-gaap:ResidentialMortgageBackedSecuritiesMember2023-12-310002002473us-gaap:AssetBackedSecuritiesMember2023-12-310002002473us-gaap:CorporateDebtSecuritiesMember2023-12-310002002473us-gaap:USTreasuryAndGovernmentMember2024-07-012024-09-300002002473us-gaap:USTreasuryAndGovernmentMember2023-07-012023-09-300002002473us-gaap:USStatesAndPoliticalSubdivisionsMember2024-07-012024-09-300002002473us-gaap:USStatesAndPoliticalSubdivisionsMember2023-07-012023-09-300002002473us-gaap:CommercialMortgageBackedSecuritiesMember2024-07-012024-09-300002002473us-gaap:CommercialMortgageBackedSecuritiesMember2023-07-012023-09-300002002473us-gaap:ResidentialMortgageBackedSecuritiesMember2024-07-012024-09-300002002473us-gaap:ResidentialMortgageBackedSecuritiesMember2023-07-012023-09-300002002473us-gaap:AssetBackedSecuritiesMember2024-07-012024-09-300002002473us-gaap:AssetBackedSecuritiesMember2023-07-012023-09-300002002473us-gaap:CorporateDebtSecuritiesMember2024-07-012024-09-300002002473us-gaap:CorporateDebtSecuritiesMember2023-07-012023-09-300002002473us-gaap:ShortTermInvestmentsMember2024-07-012024-09-300002002473us-gaap:ShortTermInvestmentsMember2023-07-012023-09-300002002473us-gaap:CashAndCashEquivalentsMember2024-07-012024-09-300002002473us-gaap:CashAndCashEquivalentsMember2023-07-012023-09-300002002473us-gaap:USTreasuryAndGovernmentMember2024-01-012024-09-300002002473us-gaap:USTreasuryAndGovernmentMember2023-01-012023-09-300002002473us-gaap:USStatesAndPoliticalSubdivisionsMember2024-01-012024-09-300002002473us-gaap:USStatesAndPoliticalSubdivisionsMember2023-01-012023-09-300002002473us-gaap:CommercialMortgageBackedSecuritiesMember2024-01-012024-09-300002002473us-gaap:CommercialMortgageBackedSecuritiesMember2023-01-012023-09-300002002473us-gaap:ResidentialMortgageBackedSecuritiesMember2024-01-012024-09-300002002473us-gaap:ResidentialMortgageBackedSecuritiesMember2023-01-012023-09-300002002473us-gaap:AssetBackedSecuritiesMember2024-01-012024-09-300002002473us-gaap:AssetBackedSecuritiesMember2023-01-012023-09-300002002473us-gaap:CorporateDebtSecuritiesMember2024-01-012024-09-300002002473us-gaap:CorporateDebtSecuritiesMember2023-01-012023-09-300002002473us-gaap:ShortTermInvestmentsMember2024-01-012024-09-300002002473us-gaap:ShortTermInvestmentsMember2023-01-012023-09-300002002473us-gaap:CashAndCashEquivalentsMember2024-01-012024-09-300002002473us-gaap:CashAndCashEquivalentsMember2023-01-012023-09-300002002473us-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-09-300002002473us-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2024-09-300002002473us-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2024-09-300002002473us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2024-09-300002002473us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialMortgageBackedSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel3Memberus-gaap:CommercialMortgageBackedSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel1Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel2Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2024-09-300002002473us-gaap:FairValueInputsLevel1Member2024-09-300002002473us-gaap:FairValueInputsLevel2Member2024-09-300002002473us-gaap:FairValueInputsLevel3Member2024-09-300002002473us-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-12-310002002473us-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-12-310002002473us-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-12-310002002473us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-12-310002002473us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel3Memberus-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel1Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel2Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310002002473us-gaap:FairValueInputsLevel1Member2023-12-310002002473us-gaap:FairValueInputsLevel2Member2023-12-310002002473us-gaap:FairValueInputsLevel3Member2023-12-310002002473us-gaap:RelatedPartyMember2024-07-012024-09-300002002473us-gaap:RelatedPartyMember2023-07-012023-09-300002002473us-gaap:RelatedPartyMember2024-01-012024-09-300002002473us-gaap:RelatedPartyMember2023-01-012023-09-300002002473bow:RenaissanceReinsuranceU.S.IncMembersrt:AMBestAPlusRatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:RenaissanceReinsuranceU.S.IncMembersrt:AMBestAPlusRatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473bow:EnduranceAssuranceCorporationMembersrt:AMBestAPlusRatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:EnduranceAssuranceCorporationMembersrt:AMBestAPlusRatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473bow:MarkelGlobalReinsuranceCompanyMembersrt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:MarkelGlobalReinsuranceCompanyMembersrt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473bow:AscotBermudaLimitedMembersrt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:AscotBermudaLimitedMembersrt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473bow:AmericanFamilyConnectPropertyAndCasualtyInsuranceCompanyMembersrt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:AmericanFamilyConnectPropertyAndCasualtyInsuranceCompanyMembersrt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473bow:PartnerReinsuranceCompanyOfTheU.S.Membersrt:AMBestAPlusRatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:PartnerReinsuranceCompanyOfTheU.S.Membersrt:AMBestAPlusRatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473us-gaap:OtherReinsurerMembersrt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473us-gaap:OtherReinsurerMembersrt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473us-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473us-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473us-gaap:RelatedPartyMember2024-09-300002002473us-gaap:RelatedPartyMember2023-12-310002002473srt:MaximumMember2024-09-300002002473srt:MinimumMember2024-09-300002002473bow:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-04-220002002473bow:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMember2024-04-220002002473bow:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberbow:NewYorkFederalReserveBankRateMember2024-01-012024-09-300002002473bow:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-01-012024-09-300002002473bow:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300002002473bow:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-07-012024-09-300002002473bow:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-01-012024-09-300002002473us-gaap:RelatedPartyMemberbow:BowheadInsuranceHoldingsLPBIHLMember2024-07-012024-09-300002002473us-gaap:RelatedPartyMemberbow:BowheadInsuranceHoldingsLPBIHLMember2023-07-012023-09-300002002473us-gaap:RelatedPartyMemberbow:BowheadInsuranceHoldingsLPBIHLMember2024-01-012024-09-300002002473us-gaap:RelatedPartyMemberbow:BowheadInsuranceHoldingsLPBIHLMember2023-01-012023-09-300002002473us-gaap:IPOMember2024-05-232024-05-230002002473us-gaap:IPOMember2024-05-230002002473bow:ClassPInterestsMember2020-10-140002002473bow:ClassPInterestsMember2023-12-012023-12-310002002473bow:ClassPInterestsMember2024-01-012024-01-310002002473bow:ClassPInterestsMember2024-09-300002002473bow:ClassPInterestsMember2024-01-012024-06-300002002473bow:A2024PlanMember2024-05-220002002473bow:A2024PlanMember2024-09-302024-09-300002002473us-gaap:RestrictedStockUnitsRSUMember2024-05-222024-05-220002002473us-gaap:RestrictedStockMember2024-05-222024-05-220002002473us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2024-01-012024-09-300002002473us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2024-01-012024-09-300002002473us-gaap:RestrictedStockUnitsRSUMember2023-12-310002002473us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300002002473us-gaap:RestrictedStockUnitsRSUMember2024-09-300002002473us-gaap:RestrictedStockMember2024-07-012024-09-300002002473us-gaap:RestrictedStockMember2024-01-012024-09-300002002473us-gaap:RestrictedStockMember2023-07-012023-09-300002002473us-gaap:RestrictedStockMember2023-01-012023-09-300002002473us-gaap:RestrictedStockMember2024-09-300002002473us-gaap:PerformanceSharesMember2024-05-222024-05-220002002473srt:MinimumMember2024-05-220002002473srt:MaximumMember2024-05-220002002473us-gaap:IPOMember2024-05-2200020024732024-05-220002002473us-gaap:PerformanceSharesMember2023-12-310002002473us-gaap:PerformanceSharesMember2024-01-012024-09-300002002473us-gaap:PerformanceSharesMember2024-09-300002002473us-gaap:PerformanceSharesMember2024-07-012024-09-300002002473us-gaap:PerformanceSharesMember2023-07-012023-09-300002002473us-gaap:PerformanceSharesMember2023-01-012023-09-300002002473us-gaap:WarrantMember2024-05-220002002473us-gaap:WarrantMember2024-05-282024-05-280002002473us-gaap:WarrantMember2024-05-222024-05-220002002473us-gaap:WarrantMember2024-09-300002002473bow:OverallotmentWarrantsMember2024-09-300002002473us-gaap:WarrantMember2024-01-012024-09-300002002473bow:OverallotmentWarrantsMember2024-01-012024-09-300002002473us-gaap:WarrantMember2024-07-012024-09-300002002473us-gaap:WarrantMember2023-07-012023-09-300002002473us-gaap:WarrantMember2023-01-012023-09-300002002473us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300002002473us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300002002473us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300002002473bow:BIHLMemberus-gaap:RelatedPartyMember2024-01-012024-09-300002002473us-gaap:RelatedPartyMemberbow:BIHLMember2024-01-012024-09-300002002473us-gaap:RelatedPartyMemberbow:BIHLMember2024-07-012024-09-300002002473us-gaap:RelatedPartyMemberbow:BIHLMember2023-07-012023-09-300002002473us-gaap:RelatedPartyMemberbow:BIHLMember2023-01-012023-09-300002002473us-gaap:RelatedPartyMemberbow:CedingFeesMember2024-07-012024-09-300002002473us-gaap:RelatedPartyMemberbow:CedingFeesMember2023-07-012023-09-300002002473us-gaap:RelatedPartyMemberbow:AmFamMember2024-07-012024-09-300002002473us-gaap:RelatedPartyMemberbow:AmFamMember2023-07-012023-09-300002002473us-gaap:RelatedPartyMemberbow:CedingFeesMember2024-01-012024-09-300002002473us-gaap:RelatedPartyMemberbow:CedingFeesMember2023-01-012023-09-300002002473us-gaap:RelatedPartyMemberbow:AmFamMember2024-01-012024-09-300002002473us-gaap:RelatedPartyMemberbow:AmFamMember2023-01-012023-09-300002002473bow:AmWINSGroupInc.BrokerMemberus-gaap:CustomerConcentrationRiskMemberbow:PremiumsWrittenGrossMember2024-01-012024-09-300002002473bow:AmWINSGroupInc.BrokerMemberus-gaap:CustomerConcentrationRiskMemberbow:PremiumsWrittenGrossMember2023-01-012023-09-300002002473bow:RyanSpecialtyGroupHoldingsInc.BrokerMemberus-gaap:CustomerConcentrationRiskMemberbow:PremiumsWrittenGrossMember2024-01-012024-09-300002002473bow:RyanSpecialtyGroupHoldingsInc.BrokerMemberus-gaap:CustomerConcentrationRiskMemberbow:PremiumsWrittenGrossMember2023-01-012023-09-300002002473bow:MarshMcLennanCompaniesBrokerMemberus-gaap:CustomerConcentrationRiskMemberbow:PremiumsWrittenGrossMember2024-01-012024-09-300002002473bow:MarshMcLennanCompaniesBrokerMemberus-gaap:CustomerConcentrationRiskMemberbow:PremiumsWrittenGrossMember2023-01-012023-09-300002002473srt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473srt:AMBestARatingMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:ReinsurerOneMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:ReinsurerTwoMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:ReinsurerThreeMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2024-01-012024-09-300002002473bow:ReinsurerOneMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473bow:ReinsurerTwoMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473bow:ReinsurerThreeMemberus-gaap:ReinsurerConcentrationRiskMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:CasualtyMember2024-07-012024-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:CasualtyMember2023-07-012023-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:ProfessionalLiabilityMember2024-07-012024-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:ProfessionalLiabilityMember2023-07-012023-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:HealthcareLiabilityMember2024-07-012024-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:HealthcareLiabilityMember2023-07-012023-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:BaleenSpecialtyMember2024-07-012024-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:BaleenSpecialtyMember2023-07-012023-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:CasualtyMember2024-01-012024-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:CasualtyMember2023-01-012023-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:ProfessionalLiabilityMember2024-01-012024-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:ProfessionalLiabilityMember2023-01-012023-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:HealthcareLiabilityMember2024-01-012024-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:HealthcareLiabilityMember2023-01-012023-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:BaleenSpecialtyMember2024-01-012024-09-300002002473us-gaap:OperatingSegmentsMemberbow:UnderwritingDivisionMemberbow:BaleenSpecialtyMember2023-01-012023-09-30

For the transition period from to

(Exact name of registrant as specified in its charter)

_________________________

(212) 970-0269

Registrant’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x   No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”and "emerging growth company" in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o  No x

Number of shares of the registrant’s common stock outstanding at October 5, 2024: 32,658,823

1.Nature of Operations and Significant Accounting Policies

Bowhead Specialty Holdings Inc. (“BSHI” and, together with its subsidiaries, “the Company”), is a Delaware domiciled insurance holding company that provides specialty property and casualty insurance products in the U.S., initially focusing on Casualty, Professional Liability and Healthcare Liability risks, which are primarily written on a non-admitted (or excess and surplus (“E&S”)) basis. On March 19, 2024, the Company amended its certificate of incorporation of Bowhead Holdings Inc. to change the name of the Company to Bowhead Specialty Holdings Inc.

BSHI conducts its business operations through three wholly-owned subsidiaries. Bowhead Specialty Underwriters, Inc. (“BSUI”) is Bowhead’s managing general agency, holding a resident insurance license in the State of Texas, and is domiciled in the State of Delaware. Bowhead Insurance Company, Inc. (“BICI”) is BSHI’s insurance company subsidiary licensed and domiciled in the State of Wisconsin. Bowhead Underwriting Services, Inc. (“BUSI”) is the Company’s services company domiciled in the State of Delaware.

BSUI is party to three Managing General Agency Agreements (“MGA Agreements”) with Homesite Insurance Company, Homesite Insurance Company of Florida, and Midvale Indemnity Company (together the “AmFam Issuing Carriers”), each of which is a wholly-owned subsidiary of American Family Mutual Insurance Company, S.I., (“AFMIC” and together with its wholly-owned subsidiaries, “AmFam”). AmFam beneficially owns approximately 18.6% of BSHI’s issued and outstanding common stock as of September 30, 2024. BSUI is also party to third-party broker agreements, allowing the direct payment of premiums from such brokers to BSUI. Through these MGA agreements, BSUI writes premium and provides claim handling services on behalf of the AmFam Issuing Carriers, and BICI assumes 100% of the premium, net of any inuring third-party reinsurance, through a Quota Share Agreement with AFMIC (the “AmFam Quota Share Agreement”). AmFam receives a ceding fee on net premiums assumed by BICI (“Ceding Fee”). BICI is also party to an Insurance Trust Agreement pursuant to which BICI provides collateral to support the obligations of the AmFam Quota Share Agreement.

The Company is organized as a single operating and reportable segment through which it offers a variety of specialty insurance products to a number of markets.

The accompanying condensed consolidated financial statements for BSHI and its wholly-owned subsidiaries (collectively, “Bowhead”) are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and do not contain all of the information and footnotes required by U.S. GAAP for complete financial statements. As such, the disclosures provided herein should be read in conjunction with the Company’s latest annual financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position. All intercompany transactions and balances are eliminated in consolidation. Interim results are not necessarily indicative of results of operations for the full year.

The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Changes in circumstances could cause actual results to differ materially from those estimates. Significant estimates in the Company’s condensed consolidated financial statements include, but are not limited to, reserves for losses and loss adjustment expenses, reinsurance recoverable on unpaid losses and loss adjustment expenses, fair value of investments, and income taxes.

Management bases its estimates and assumptions on historical experience and other factors, including the current economic environment and on various other judgments that it believes to be reasonable under the circumstances. Management periodically reviews its estimates and assumptions and makes adjustments thereto when facts and circumstances dictate. Changes in accounting estimates and underlying assumptions are recognized prospectively in the condensed consolidated financial statements.

Basic earnings per share is calculated by dividing net income by the weighted-average common stock outstanding for the period. Diluted earnings per share follows the basic earnings per share calculation, except the denominator is increased to reflect the dilution that may occur if equity based awards are converted into common stock equivalents, as calculated using the treasury stock method. Anti-dilutive equity based awards, which are awards that would increase earnings per share upon conversion under the treasury stock method, are excluded in the calculation of diluted earnings per share.

See Note 10 for the computation of basic and diluted earnings per share.

On May 9, 2024, the Company effected a 240 thousand-for-1 forward split of each outstanding share of BSHI’s common stock, par value $0.01 per share. As a result of the forward stock split, 100 shares of common stock issued and outstanding was increased to 24,000,000 shares of issued and outstanding common stock, without any change in the par value per share. All share, per share and related information presented in the condensed consolidated financial statements and accompanying notes have been retroactively adjusted, where applicable, to reflect the impact of the forward stock split.

On May 28, 2024, the Company completed an upsized initial public offering (the “IPO”) with the sale of 8,658,823 shares of common stock at a price to the public of $17.00 per share, including 1,129,411 shares sold upon the exercise in full of the underwriters’ option to purchase additional shares. After underwriter discounts, commissions and offering expenses, net proceeds to the Company from the IPO were approximately $131.0 million.

Other insurance-related income includes fees associated with the issuance of policies, which are earned on the effective date of the underlying policy, and revenue we receive for providing insurance-related services, which are earned on a pro-rata basis over the service period.

Bowhead Insurance Holdings LP (“BIHL”), which was previously a majority owner of the Company, issued Class P Interests to certain employees in connection with the Company’s pre-IPO employee compensation structure. Each Class P Interest is structured as a profit interest award and entitles the employees to profits after the partners of BIHL receive a return of their initial investment. The Class P Interests are accounted for as equity under accounting standards codification (“ASC”) 718, Compensation – Stock Compensation (“ASC 718”). The fair value of the compensation cost incurred under these awards is measured at the date of grant based on the fair value of the award and is recognized as operating expenses within the Condensed Consolidated Statements of Income and Comprehensive Income, using a graded method over the requisite service period. The Company recognizes any award forfeitures when they occur.

On May 22, 2024, the Company’s Board of Directors (the “Board”) approved and adopted the 2024 Omnibus Incentive Plan (the “2024 Plan”), which provides for the grant of stock options (including incentive stock options (“ISOs”) and nonqualified stock options), stock appreciation rights, restricted stock, restricted stock units (“RSUs”), other stock-based awards, stock bonuses, cash awards and substitute awards.

Under the 2024 Plan, the Company granted RSUs to the Company’s employees and certain Board directors, and performance stock units (“PSUs”) to its chief executive officer (the “CEO”).

The RSUs are subject to a service condition and are accounted for as equity under ASC 718. The RSUs are valued based on the fair value of the underlying award, which is Bowhead’s common stock, at the date of grant. The Company recognizes the compensation cost for the RSUs on a straight-line basis over the awards’ vesting period as operating expenses within the Company’s Condensed Consolidated Statements of Income and Comprehensive Income. The Company recognizes any award forfeitures when they occur.

The PSUs are subject to both a service and a market condition, and may be settled in cash upon the occurrence of an event that is outside of the Company’s control. The PSUs are accounted for as mezzanine equity on the Company’s Condensed Consolidated Balance Sheets under ASC 718 until the vesting date. The PSUs are measured at fair value based on a Monte Carlo simulation model. The Company recognizes the compensation cost for PSUs on a straight-line basis over the award’s vesting period as operating expenses within the Company’s Condensed Consolidated Statements of Income and Comprehensive Income. If the market condition is not achieved, previously recognized compensation expense is not reversed. The Company recognizes any award forfeitures when they occur.

On May 22, 2024, the Board approved the issuance of warrants to AmFam, a related party of the Company, to purchase shares of the Company’s common stock. The warrants are subject to a service condition and are accounted for as equity under ASC 718. The fair value of the warrants are based on Black-Scholes-Merton pricing models. The Company recognizes compensation cost for the warrants on a quarterly basis over the awards’ vesting period as warrant expense within the Company’s Condensed Consolidated Statements of Income and Comprehensive Income. The Company recognizes any award forfeitures when they occur.

See Note 9 for additional information on the Company’s stock-based compensation.

Costs associated with the establishment of a senior secured revolving credit facility have been deferred and are amortized using the straight-line method over the terms of such instruments. Unamortized deferred financing fees are presented within other assets on the Company’s Condensed Consolidated Balance Sheets, and amortization expenses related to such costs are included in credit facility interest expenses and fees in the Company’s Condensed Consolidated Statements of Income and Comprehensive Income.

The Company has not adopted any new accounting standards during the three and nine months ended September 30, 2024.

The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company is provided an option to adopt new or revised accounting guidance as an “emerging growth company” under the JOBS Act either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as private companies, including early adoption when permissible.

There are no prospective accounting standards which, upon their effective date, would have a material impact on the Company’s condensed consolidated financial statements.

2.Investments

The following table summarizes the amortized cost and fair value of the Company’s fixed maturity securities, all of which are classified as available for sale:

a)Contractual Maturity of Fixed Maturity Securities

The amortized cost and fair value of fixed maturity securities at September 30, 2024 and December 31, 2023, by contractual maturity, are shown below. Actual maturities may differ from contractual maturities because certain issuers may have the right to call or prepay obligations.

b)Net Investment Income

The components of net investment income were derived from the following sources:

c)Net Realized Investment Gains (Losses)

There were $18.1 thousand and $16.2 thousand net realized investment losses for the three and nine months ended September 30, 2024 from the sale of investments and nil for the three and nine months ended September 30, 2023.

d)Restricted Assets

The Company is required to maintain assets as collateral in trust accounts to support the obligations of the AmFam Quota Share Agreement. The assets held in trust include fixed maturity securities, short-term investments and restricted cash and cash equivalents. The Company is entitled to interest income earned on these restricted assets, which is included in net investment income in the Condensed Consolidated Statements of Income and Comprehensive Income.

The following table summarizes the value of the Company’s restricted assets disclosed in the Condensed Consolidated Balance Sheets:

e)Gross Unrealized Losses

The following table summarizes available for sale securities in an unrealized loss position, the fair value and gross unrealized loss by length of time the security has been in a continual unrealized loss position:

All of the securities in an unrealized loss position are rated investment grade. For fixed maturity securities that management does not intend to sell or are required to sell, there is no portion of the decline in value that is considered to be due to credit factors that would be recognized in earnings. Declines in value are considered to be due to non-credit factors and are recognized in Other Comprehensive Income.

The Company has evaluated its fixed maturity securities in an unrealized loss position and concluded that the unrealized losses are due primarily to temporary market and sector-related factors rather than to issuer-specific factors. None of these securities are delinquent or in default under financial covenants. Based on the assessment of these issuers, the Company expects them to continue to meet their contractual payment obligations as they become due.

3.Fair Value Measurements

•Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

•Level 2: Significant other observable inputs other than Level 1 inputs, such as quoted prices in active markets for similar assets or liabilities, quoted prices in inactive markets for identical assets or liabilities, or other inputs that are directly or indirectly observable through market-corroborated inputs, such as interest rates, yield curves, prepayment speeds, default rates, or loss severities.

•Level 3: Significant unobservable inputs used to measure fair value to the extent that relevant observable inputs are not available, and that reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the measurement date.

The Company’s investments in fixed maturity securities, all of which are classified as available for sale, are carried at fair value. All of the Company’s fixed maturity securities investments were priced by independent pricing services. The prices provided by the independent pricing services are estimated based on observable market data in active markets utilizing pricing models and processes, which may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, sector groupings, matrix pricing and reference data. Under certain circumstances, if a vendor price is unavailable, a price may be obtained from a broker. The pricing services may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs are available for each security evaluation on any given day. The pricing services used by the Company have indicated that they will only produce an estimate of fair value if objectively verifiable information is available. The determination of whether markets are active or inactive is based upon the volume and level of activity for a particular asset class.

The fair values of short-term investments approximate their carrying values due to their short-term maturity.

The following table presents the Company’s investments measured at fair value by level:

4.Reserve for Losses and Loss Adjustment Expenses

The table below provides a reconciliation of the beginning and ending reserve balances for the nine months ended September 30, 2024 and September 30, 2023:

During the nine months ended September 30, 2024 and 2023, there was nil and $0.6 million of prior accident year unfavorable loss development, respectively.

5.Premiums and Reinsurance Related Information

The following table summarizes the effects of reinsurance on the Company’s written and earned premiums and losses and loss adjustment expenses:

6.Leases

The Company and its subsidiaries had a right to use two distinct office spaces in New York and Chicago under separate lease agreements. All of the Company’s leases are classified as operating leases and the Company was not party to any finance lease arrangements as of and during the three and nine months ended September 30, 2024 and 2023. The right of use (“ROU”) asset and lease liability balances as of September 30, 2024 were $3.8 million and $4.1 million, respectively, and the ROU asset and lease liability balances as of December 31, 2023, were $0.5 million and $0.7 million, respectively.

The terms of the operating leases range from three and a half years to five years, from the dates the Company gained access to the spaces, through and to the stated termination dates, which expire in May 2025 and December 2027, respectively. Although the Chicago operating lease agreement contains an option to extend the lease term, the Company is not reasonably certain it will exercise this option. Due to this uncertainty, in the measurement of the lease liability, the Company has excluded the period covered by the renewal option from the lease terms.

The Chicago operating lease agreement contains rent escalation features that are reflected in the Company’s lease liability balances. Since the discount rates implicit in the leases are not readily available, the Company used an incremental borrowing rate to discount the remaining lease payments in measuring the lease liability. The Company did not incur any initial direct costs or make prepayments in connection with its lease arrangements; as such, these amounts are not reflected in the ROU asset.

Lease expense for the three months ended September 30, 2024 and 2023 was $0.4 million and $0.1 million, respectively, and for the nine months ended September 30, 2024 and 2023 was $0.8 million and $0.4 million, respectively. Lease expense is recognized on a straight-line basis over the lease term in operating expenses within the Condensed Consolidated Statements of Income and Comprehensive Income. The Company has immaterial variable lease costs and no short-term leases for the three and nine months ended September 30, 2024 and 2023.

The following table summarizes the Company’s future minimum lease payment obligations under non-cancelable operating leases as of September 30, 2024:

The weighted average remaining lease term and weighted average discount rate for the Company’s operating leases as of September 30, 2024 were 3.2 years and 4.9%, respectively.

Cash paid for operating leases for the three months ended September 30, 2024 and 2023 was $0.5 million and $0.2 million, respectively, and for the nine months ended September 30, 2024 and 2023 was $0.9 million and $0.6 million, respectively. There were no non-cash additions from new and remeasured leases that resulted in an increase to the ROU asset and lease liability.

7.Revolving Credit Facility

On April 22, 2024, the Company entered into a Credit Agreement (the “Credit Agreement”) with certain lenders and JPMorgan Chase Bank, N.A., as administrative agent, swingline lender and issuing bank. The Credit Agreement provides for a senior secured revolving credit facility (the “Facility”) in the aggregate principal amount of $75 million, which includes a $5 million sub-facility for letters of credit. All obligations under the Facility and obligations in respect of certain cash management services and swap agreements with the lenders and their affiliates are (i) unconditionally guaranteed by certain of the Company’s subsidiaries and (ii) secured by a first-priority perfected lien in substantially all of the Company’s and the subsidiaries guarantors’ assets. The Credit Agreement contains certain customary covenants, including financial maintenance covenants. The Company was in compliance with all of the Facility’s covenants as of September 30, 2024. The Facility matures on the earlier of April 22, 2027, or 91 days prior to the MGA Agreement termination date where no MGA Agreement replacement is found. The Company may request that the lenders extend the maturity date by an additional year, provided that the request is made no earlier than 90 days and no later than 55 days prior to the first or second anniversary of the effective date of the Facility.

Interest on the Facility is based on a floating rate indexed to either (i) adjusted term Secured Overnight Financing Rate (“SOFR”) plus an applicable rate, (ii) the greater of (a) the prime rate, (b) the Federal Reserve Bank of New York rate plus 0.5% per annum and (c) the adjusted term SOFR rate for a one-month interest period plus 1% per annum, plus an applicable rate, or (iii) the adjusted daily simple SOFR plus an applicable rate. As of September 30, 2024, the Company did not have any borrowings outstanding under the Facility.

The Company had unamortized deferred financing fees related to the Facility of $1.5 million as of September 30, 2024, and recognized amortization expenses for deferred financing fees of $0.3 million and $0.5 million for the three and nine months ended September 30, 2024, respectively.

8.Stockholders' Equity

The Company’s authorized capital stock consists of 400,000,000 shares of common stock, par value $0.01 per share and 100,000,000 shares of preferred stock, par value $0.01 per share.

During the three months ended September 30, 2024 and 2023, BIHL contributed additional paid-in capital of nil and $22.3 million, respectively, to the Company without issuing additional shares.

During the nine months ended September 30, 2024 and 2023, BIHL contributed additional paid-in capital of $4.5 million and $53.6 million, respectively, to the Company without issuing additional shares.

On May 23, 2024, the Company completed an upsized IPO with the sale and issuance of 8,658,823 shares of its common stock at a price of $17.00 per share. The Company received net proceeds from the offering of $131.0 million.

9.Stock-Based Compensation

On October 14, 2020, BIHL established and authorized for issuance 40,750,000 Class P Interests for certain key employees of the Company. In December 2023 and January 2024, BIHL authorized for issuance an additional 4,766,315 and 553,048 Class P Interests, respectively, for a total of 46,069,363 Class P Interests authorized for issuance. Each grant is subject to vesting and repurchase provisions, as well as other conditions.

On June 30, 2024, in preparation for the dissolution of BIHL, the general partner of BIHL approved the valuation and the acceleration of unvested Class P Interests, which prior to the dissolution of BIHL are exchanged for shares of the Company’s common stock held by BIHL with no further vesting conditions. Accordingly, on June 30, 2024, the Company accelerated the remaining unrecognized compensation cost associated with the Class P Interests of $1.3 million through operating expenses within the Company’s Condensed Consolidated Statements of Income and Comprehensive Income. On September 9, 2024, in contemplation of the dissolution of BIHL, the general partner of BIHL approved the full vesting of unvested Class P Interests, and the holders of outstanding Class P Interests subsequently received a distribution of shares of the Company’s common stock held by BIHL with no further vesting conditions. See Note 15 for additional information on the dissolution of BIHL.

On May 22, 2024, the Board approved and adopted the 2024 Plan, which provides for the grant of stock options (including ISOs and nonqualified stock options), stock appreciation rights, restricted stock, RSUs, other stock-based awards, stock bonuses, cash awards and substitute awards.

A total of 3,152,941 shares of common stock were initially authorized and reserved for issuance under the 2024 Plan. The reserve increases on January 1 of each year, starting in 2025, by an amount equal to the lesser of: (a) 2.0% of the fully-diluted shares on the preceding December 31, and (b) a smaller amount as determined by the Board.

On May 22, 2024, the Board approved the grant of RSUs to the Company’s employees and certain Board directors, and PSUs to its CEO. As of September 30, 2024, 895,262 shares of common stock were granted under the 2024 Plan.

On May 22, 2024, the Board approved the grant of 762,115 RSUs with a grant-date fair value of $17.00 per share. Additional RSUs were granted after May 22, 2024 based on the grant-date fair value of Bowhead’s common stock. The RSUs issued to employees and a one-time issuance to one of the Company’s directors have a four-year vesting period. These RSUs vest 20% per year for the first three years following issuance and 40% at the end of the fourth year, and are contingent upon the employee’s continuous employment or the director’s continuous service as a director with the Company throughout the vesting period. In addition, the RSUs issued to directors of the Company under the Company’s non-employee director compensation policy are contingent upon the director’s continuous service as a director through the vesting date, which is the earliest of: (a) the one-year anniversary of the grant date, (b) the date of the regular annual meeting of the Company’s stockholders held following the grant date, or (c) the date of the consummation of a change in control.

The following table provides a summary of RSU activities during the nine months ended September 30, 2024:

The Company recognizes the compensation cost for the RSUs on a straight-line basis over the awards’ vesting period.